Loading…
Comparison of 6-s-cis- and 6-s-trans-Locked Analogs of 1α,25-Dihydroxyvitamin D3 Indicates That the 6-s-cis Conformation Is Preferred for Rapid Nongenomic Biological Responses and That Neither 6-s-cis- nor 6-s-trans-Locked Analogs Are Preferred for Genomic Biological Responses
The hormone 1α,25-dihydroxyvitamin D3[ 1α,25(OH)2D3] generates biological responses via both genomic and rapid, nongenomic mechanisms. The genomic responses utilize signal transduction pathways linked to a nuclear receptor (VDRnuc) for 1α,25(OH)2D3, while the rapid responses are believed to utilize...
Saved in:
Published in: | Molecular endocrinology (Baltimore, Md.) Md.), 1997-09, Vol.11 (10), p.1518-1531 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The hormone 1α,25-dihydroxyvitamin
D3[
1α,25(OH)2D3]
generates biological responses via both genomic and rapid, nongenomic
mechanisms. The genomic responses utilize signal transduction pathways
linked to a nuclear receptor (VDRnuc) for
1α,25(OH)2D3, while
the rapid responses are believed to utilize other signal transduction
pathways that may be linked to a putative membrane receptor for
1α,25(OH)2D3. The
natural seco steroid is capable of facile rotation about its 6,7 single
carbon bond, which permits generation of a continuum of potential
ligand shapes extending from the 6-s-cis (steroid like) to
the 6-s-trans (extended). To identify the shape of
conformer(s) that can serve as agonists for the genomic and rapid
biological responses, we measured multiple known agonist activities of
two families of chemically synthesized analogs that were either locked
in the 6-s-cis (6C) or 6-s-trans (6T)
conformation. We found that 6T locked analogs were inactive or
significantly less active than
1α,25(OH)2D3 in both
rapid responses (transcaltachia in perfused chick intestine,
45Ca2+ influx in ROS
17/2.8 cells) and genomic (osteocalcin induction in MG-63 cells,
differentiation of HL-60 cells, growth arrest of MCF-7 cells, promoter
transfection in COS-7 cells) assays. In genomic assays, 6C locked
analogs bound poorly to the VDRnuc and were
significantly less effective than
1α,25(OH)2D3 in the
same series of assays designed to measure genomic responses. In
contrast, the 6C locked analogs were potent agonists of both rapid
response pathways and had activities equivalent to the conformationally
flexibile
1α,25(OH)2D3; this
represents the first demonstration that 6-s-cis locked
analogs can function as agonists for vitamin D responses. |
---|---|
ISSN: | 0888-8809 1944-9917 |
DOI: | 10.1210/mend.11.10.9993 |